February 29, 2024
ProQuest, part of Clarivate, launches AI-powered research assistant. ProQuest, part of Clarivate, is collaborating with its community of educators to address these issues by harnessing AI's powerful abilities and applying them in a responsible, reliable research companion for students. Currently in beta with top universities, ProQuest Research Assistant achieves a milestone in next generation content discovery by enabling students to use conversational inquiry to explore vast, vetted and authoritative content. ProQuest Research Assistant is being tested in an academic library staple: ProQuest One Literature, a destination resource built on a foundation of high quality, authoritative content – an extraordinary range of full text prose and poetry as well as plays, periodicals, essays, video, imagery and editor-developed topical content. ProQuest is developing its AI initiatives in alignment with traditional academic principles and strong community governance. The rigorous approach to testing and validating results is shaping a powerful new research tool that will be integrated in ProQuest solutions across major disciplines. [Full Announcement].
February 28, 2024
Clarivate Reports Fourth Quarter and Full Year 2023 Results. Clarivate reported results for the fourth quarter and full year ended December 31, 2023. [Full Announcement].
February 23, 2024
Clarivate recognized in the WTR 1000 2024 for trademark business. Clarivate has been recognized in the WTR 1000 2024 by the World Trademark Review. This guide identifies the top trademark professionals and firms in over 80 jurisdictions around the globe. Clarivate has been named as highly recommended in the following practice areas in the WTR 1000 2024, including Trademark Management, Searching and Watching, and Renewals and Recordals. [Full Announcement].
February 20, 2024
Clarivate launches new Center for Intellectual Property and Innovation Research. Clarivate launched the Clarivate Center for IP and Innovation Research, a new expert unit which will guide corporations and research organizations in their mission to create innovative ideas, valuable technology and brand IP assets. The Center will combine more than 60 years of intellectual property management and data-creation with analysis experience from Clarivate, pioneering high-performance benchmarks and practice. [Full Announcement].
February 19, 2024
2024 Journal Citation Reports: Changes in Journal Impact Factor category rankings to enhance transparency and inclusivity. The scholarly landscape is witnessing a significant increase in both the quantity and sophistication of fraudulent behaviors, posing a substantial threat to the integrity of the scholarly record. Clarivate has an unwavering commitment to safeguard the integrity of the scholarly record and recognize a pressing need for indicators of trustworthiness at the journal level. Over the past few years, Clarivate has implemented a series of policy changes for the Journal Citation Reports aimed at aligning coverage between the Web of Science Core Collection and the JCR, providing more transparency of the data underlying JCR metrics encouraging a more inclusive, more holistic way of comparing journals. Recent changes to the JCR have included the addition of profile pages for journals indexed in the Arts & Humanities Citation Index and Emerging Sources Citation Index and the introduction of the Journal Citation Indicator in 2021. The JCI is field-normalized to facilitate the comparison of journals across different disciplines, including the arts and humanities. We also extended the Journal Impact Factor to AHCI and ESCI journals in 2023 so that it now encompasses all quality journals in the Web of Science Core Collection. [Full Announcement].
February 12, 2024
Clarivate partners with the Financial Times to power its Business School Rankings. Clarivate has partnered with the Financial Times for the sixth consecutive year to provide it with trusted high-quality data for three of its business school rankings, including the Global MBA Rankings. The FT is one of the world's leading business news organizations, recognized internationally for its authority, integrity and accuracy. Its annual business school rankings provide valuable insights for prospective students seeking a high-quality business education. The rankings show how institutions have performed and progressed in the past year, influencing institutional strategy including talent acquisition. The rankings include the Global MBA Rankings, published today, and the Online MBA and Executive MBA rankings which will follow in March and October, respectively. [Full Announcement].
February 1, 2024
Clarivate Completes Refinancing of Term Loan and Revolver Extension. Clarivate announced that it has successfully completed the refinancing of its term loan B credit facility and the extension of the maturity date of its revolving credit facility. Pursuant to an amendment to the Company's existing credit agreement dated as of October 31, 2019, the Company refinanced all of its existing term loans with a new $2.150 billion tranche of term loans maturing in 2031, with a reduced interest rate margin of 275 basis points per annum in the case of loans bearing interest by reference to term SOFR. The new term loan facility effectively extends the maturity of the Company's existing term loans by approximately 5 years. [Full Announcement].
January 29, 2024
Clarivate launches Web of Science Grants Index to help researchers optimize funding strategies. Clarivate launched the Web of Science Grants Index. The new solution is designed to provide a more comprehensive, enriched view of the funding landscape, empowering researchers to make confident, informed decisions when they seek research funding. The Grants Index offers an enriched view of the global funding landscape with 5.2M+ awarded grant records sourced from over 400 funders worldwide to help researchers better investigate previous successes in their field by funder. Researchers can easily identify and analyze previously funded projects, exploring grant details including principal and co-principal investigators, project description and links to published outcomes, all in the Web of Science research discovery environment. In doing so, researchers can more effectively position their projects and increase their chances of a successful bid with a funding agency. [Full Announcement].
January 24, 2024
Clarivate to Report Fourth Quarter and Full Year 2023 Results on February 27, 2024. Clarivate announced it will report its financial results for the fourth quarter and full year 2023 before the market opens on Tuesday, February 27. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website. The Company will host a conference call and webcast on Tuesday, February 27 at 9:00 AM Eastern Time to review the results. [Full Announcement].
January 22, 2024
Clarivate announces commencement of term loan refinancing transaction. Clarivate announced the launch of a process to refinance the Company's 2026 Term Loan B credit facility that would extend the maturity to 2031 for a new combined term loan amount of $2.2 billion. The Company also announced that it expects to record a non-cash goodwill impairment charge in the range of approximately $800 million to $900 million in the fourth quarter 2023, across the Intellectual Property and Life Sciences & Healthcare segments. [Full Announcement].
January 18, 2024
Report highlights disparities in UK's research and innovation investment. A new report from the Higher Education Policy Institute (www.hepi.ac.uk) sheds light on the inadequacies in the UK's efforts to ‘level up' research and innovation across regions, drawing comparisons with Germany and the United States. The report, authored by Jonathan Adams, Jonathan Grant, David Smith and Martin Szomszor, reveals critical insights into the disparities and shortcomings in current investment strategies. [Full Announcement].
January 8, 2024
Clarivate identifies thirteen potential blockbuster drugs and gamechangers in annual Drugs to Watch report. Clarivate announced the release of its annual Drugs to Watch report. The report provides in-depth predictive analysis of drugs with the potential for standout commercial and/or clinical success. The report, a key industry resource in the evolving healthcare landscape, has identified over 85 Drugs to Watch over the 11-year course of its publication. This year, analysts identified 13 new-to-market therapeutics and drugs poised to launch in 2024 which Clarivate predictive analytics project will achieve blockbuster status by 2029 or deliver game-changing benefits to patients. These promising advancements include a broad spectrum of therapeutic innovation for conditions including breast cancer, hemophilia A, sickle cell disease, Crohn's disease, ulcerative colitis, respiratory syncytial virus and multiple myeloma, among others. [Full Announcement].
December 20, 2023
Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China release annual Report to reveal future innovation in engineering science and technology. Clarivate released Engineering Fronts 2023 , along with the Chinese Academy of Engineering, and the Higher Education Press of China. This report is the seventh annual collaboration and aims to track the development trends of engineering science and technology by identifying key research areas. The new report identifies a total of 187 pivotal research fronts, encompassing forward-looking, leading and exploratory research areas of engineering. Among these, 93 engineering research fronts have been pinpointed to theoretical exploration – derived using a synthesis of citation data extracted from the Web of Science™ from Clarivate together with nominations by experts at the CAE. [Full Announcement].
December 18, 2023
Empowering research institutions to navigate an evolving landscape: Introducing our new academic research council. The academic community is confronting a rising tide of challenges, from dwindling funding success rates to acute university staff shortages. These critical pain points underscore an urgent need for actionable insights and decisive strategies. To address these challenges, Clarivate has created a research council that aims to bridge the gap between theoretical and tangible solutions. Comprised of 15 leaders at top research institutions from across the globe, the council includes members from both research offices and libraries. The unique composition is designed to foster collaborative solutions to pressing issues. [Full Announcement].
December 14, 2023
Clarivate partners with Singapore's National Library Board. Clarivate has successfully implemented library software solutions from Innovative for Singapore's National Library Board library system. NLB's library patrons can now enjoy an elevated user experience and new features such as an intuitive user interface and custom catalogs as they access NLB's library catalogue. The Polaris Integrated Library System and Vega Discover applications from Innovative provide automation solutions for library staff and patrons. These solutions help to improve the library experience for staff and patrons, whether in the physical library or online. Custom API support designed by Clarivate supports local systems such as self-check kiosks, book sorters, the NLB Mobile app and reservation lockers to improve efficiency. [Full Announcement].
Innovation and Customer Growth for Alma throughout 2023. The end of the 2023 is approaching and it's been another successful year for Alma. The combination of new features and functionality, additional customers choosing and implementing the service, and a vision to further leverage forward-looking technology is taking Alma to a new level in the area of library unified resource management. Over 400 enhancements were delivered, with many coming from ideas originating within the user community and significant Involvement from customers across the development process. Alma continues to grow, with more than 180 libraries choosing Alma in 2023 and over 130 implementing the service. This brings the total number of libraries selecting Alma to over 2500. [Full Announcement].
December 8, 2023
Discovering new insights from early-career scholarship through the addition of >172M linked cited references from ProQuest dissertations and theses on the Web of Science. Students and researchers can easily locate new sources of research on diverse topics with the enriched ProQuest Dissertations & Theses Citation Index, as well as easily showcase their work and monitor impact over time. Earlier this year, we integrated records for more than 5.5 million dissertations and theses from ProQuest Dissertations & Theses Global into the Web of Science to provide students and researchers with a more holistic and comprehensive view of the scholarly landscape within a single platform. This integration opened an avenue for researchers from over 4,100 institutions in more than 60 countries to showcase their achievements to peers and evaluators. Researchers at every career stage can claim their dissertation or thesis in their Web of Science Researcher Profile to increase the visibility of their work in a database visited daily by tens of thousands of users worldwide. [Full Announcement].
December 7, 2023
Clarivate Connects 172M+ Cited References from ProQuest Dissertations and Theses to the Web of Science. Clarivate announced it has enriched ProQuest Dissertations & Theses Citation Index, integrating over 172 million cited references from ProQuest Dissertations & Theses Global within the Web of Science platform and interconnecting both platforms. ProQuest Dissertations & Theses Citation Index opens new possibilities in the research workflow for students and researchers, enabling them to explore the development of a topic across varied, multidisciplinary research outputs or to look back at the research foundation of post-graduate works. This enhancement deepens the connection between published and unpublished scholarship, enriching the entire research experience. [Full Announcement].
December 5, 2023
Clarivate expands partnership with VeriSIM Life to accelerate and de-risk research and drug development. Clarivate announced the launch of VeriSIM Life Translational Index on Cortellis Drug Discovery Intelligence by Clarivate. The integrated workflow provides customers with a diverse array of predictive compound safety and efficacy insights, including bioavailability, hepatic and renal clearance, clinical toxicity, first-in-human dose and more. The new solution serves as the next phase of an expanding partnership between Clarivate and VeriSIM Life, the leading artificial intelligence (AI)-enabled, R&D decisions de-risker for breakthrough drug development, announced earlier this year. [Full Announcement].
November 19, 2023
Clarivate reveals World's Influential Researchers in Highly Cited Researchers 2023 list. Clarivate, a global leader in connecting people and organizations to intelligence they can trust to transform their world, today revealed its 2023 list of Highly Cited Researchers – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scientific Information have recognized 6,849 Highly Cited Researchers in 2023, from more than 1,300 institutions in 67 nations and regions. The evaluation and selection process draws on data from the Web of Science citation index, together with analysis performed by bibliometric experts and data scientists at the ISI at Clarivate. [Full Announcement].